DESCRIPTION {#S1}
===========

A 54-year-old man sustained third-degree burns to 50% total body surface area. He was transferred to our facility in septic shock on day five after injury. Broad-spectrum antibiotics, burn excision, and resurfacing with allograft were initiated. Two weeks later, a new wound infection was identified ([Fig 1](#F1){ref-type="fig"}).

QUESTIONS {#S2}
=========

**What is the differential diagnosis?How is the diagnosis made?What is the treatment?What is the prognosis?**

DISCUSSION {#S3}
==========

Confluent patches of a white-grey substance are evident both on and beneath the allograft ([Fig 1](#F1){ref-type="fig"}). The broad-spectrum antibiotics suggest an opportunistic fungal infection. The differential diagnosis includes multiple pathogenic yeast and mold species. *Candida* spp are the most common burn wound colonizers and have historically been the most common invasive mycosis.[@B1] Today, the most frequent invasive fungal pathogens include (in decreasing order): *Aspergillus, Fusarium, Candida, Mucor, Rhizopus, Microsporia*, and *Alternara* spp.[@B2] Deadly non-albicans *Candida* spp such as *C. tropicalis and C. krusei* are also becoming more common.[@B3]

The diagnosis of an invasive fungal burn wound infection is most often made by the identification of microorganisms in viable tissue (below or adjacent to the burn wound) via biopsy.[@B1]^,^[@B2] *Candida* infections may not always fit this criteria. Thus, concurrent wound and blood cultures yielding *Candida* spp should be substituted as evidence of an invasive infection.[@B1] In this case, the fungal burden was so substantial as to be easily seen at the bedside ([Fig 1](#F1){ref-type="fig"}). However, a more specific diagnosis (i.e. species) is difficult based upon clinical findings alone. In this case, a tissue sample was obtained from the area of greatest suspicion and expedited to the microbiology laboratory for histopathologic analysis. Invasive hyphae and spores characteristic of *Aspergillus* spp were identified and appropriate treatment was initiated. Wound cultures were also obtained and confirmed the presence of *Aspergillus* spp ([Fig 2](#F2){ref-type="fig"}). It should be noted however, that fungal cultures (especially blood) are not always reliable and may require a long incubation time of one to two weeks before a definitive diagnosis can be made.[@B1]^,^[@B2]^,^[@B4] Thus, if the diagnosis remains unclear, newer non-culture-based adjuncts such as a galactomannan EIA, (1→3)-β-D-glucans assay (Associates of Cape Cod Fungitell assay for invasive mycoses), or a PCR-based modality for *Aspergillus*-specific fungal genes should be considered.[@B5]

The invasive nature of molds such as *Aspergillus* spp mandate aggressive and prompt surgical excision until margins are histopathologically clear of fungal elements, in addition to the administration of systemic anti-fungal agents.[@B1]^,^[@B5] Thus, treatment should not be delayed while awaiting culture results. Skin autografting should also be avoided until the infection has resolved.[@B3] The systemic administration of targeted anti-fungal agents is important due to the angioinvasive nature of many molds such as *Aspergillus* spp. The first-line treatment is now Voriconazole, with Amphotericin B as second line due to its harsh adverse effects.[@B5] Antifungal therapy alone is inadequate and must only be used in conjunction with surgical debridement.[@B1] Currently, no topical antimicrobial agents have been found to be effective against invasive mold infections.[@B6] Some silver based antimicrobial dressings have been shown to be successful at eradicating *Aspergillus* spp in vitro but have yet to be proven effective in vivo.[@B6] In our case, the mold was successfully eradicated using a pulse lavage device with Amphotericin B solution to irrigate the wounds, in addition to surgical excision and systemic Voriconazole.

Infection with *Aspergillus* spp is associated with an especially high mortality. In one recent study, the mold accounted for 93% of all deaths attributed to fungus.[@B7] When compared to other (non-mold) mycotic infections found in burn patients, *Aspergillus* spp are independently associated with a nearly 12-fold increase in the odds-ratio of death.[@B4] This is most likely a reflection of the angioinvasive tendencies of the mold.

![Burn wound on post-operative day three after resurfacing with allograft.](eplasty14ic05_fig1){#F1}

![Light microscopy of *Aspergillus* spp with lactophenol cotton blue stain cultured from burn wound.](eplasty14ic05_fig2){#F2}
